Perspectives of Targeted Chemotherapy With Delamanid in the Treatment Regimens of Those With Multiple/Extensive Drug Resistant Tuberculosis. A Success, Chance or Uncertainty?

The article presents the review of current publications, clinical recommendations and guidelines written by foreign authors and devoted to treatment of drug resistant tuberculosis with delamanid. According to the publications, delamanid and its combinations with other anti-tuberculosis are highly effective when used for treatment of respiratory MDR tuberculosis: 74.5% of patients achieved the complete sputum conversion by the 6th month of treatment.